Thomas Marbury - Concepedia

Author

Thomas Marbury

Also Known As

A. Hutchcraft, Abhya Gupta, Giridhar Tirucherai, J 1%, Richard Preston, S.K. Swan, T C Marbury, T MARBURY, T Marbury, T. C. Marbury

259

Publications

7.8K

Citations

H-Index

106

Concepts

All Affiliations

Orlando Clinical Research Center DaVita Clinical Research (United States)Clinical Pharmacology of Miami Merck & Co., Inc., Rahway, NJ, USA (United States)University of Miami

About

Thomas Marbury is an author at Orlando Clinical Research Center specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	61	3.7K
2	Health Sciences	7	7	402
3	Natural Sciences	1	1	45
4	Public Health	1	1	129
5	Biochemistry	1	1	45

Thomas Marbury

135

Publications

7.3K

Citations

H-Index

Page 1

	Year	Citations
Anaritide in Acute Tubular Necrosis Robin L. Allgren, Thomas Marbury, Sahinur Rahman, New England Journal of Medicine	1997	443
Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis Xiaoli Wang, Giridhar Tirucherai, Thomas Marbury, The Journal of Clinical Pharmacology Healthy SubjectsDialysis TherapyPharmacotherapyPharmacodynamic ModelingThrombosis	2015	280
Comparative Efficacy of Olmesartan, Losartan, Valsartan, and Irbesartan in the Control of Essential Hypertension Suzanne Oparil, Steven G. Chrysant, Thomas Marbury, Journal of Clinical Hypertension	2001	263
Atrial natriuretic factor in oliguric acute renal failure Julia B. Lewis, Mahmoud Salem, Glenn M. Chertow, American Journal of Kidney Diseases Cardiovascular DiseaseMedicineKidney FailureAcute Kidney InjuryChronic Kidney Disease	2000	253
Clinical improvement in psoriasis with specific targeting of interleukin-23 Tamara Kopp, Elisabeth Riedl, Christine Bangert, Nature Autoimmune DiseaseMedicineClinical ImprovementImmunologyClinical Dermatology	2015	205
Effect of Renal Insufficiency on the Pharmacokinetics of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor Arthur Bergman, Josée Côté, Bingming Yi, Diabetes Care Healthy SubjectsPharmacotherapyPharmacokineticsRenal FunctionRenal Excretion	2007	194
Repaglinide versus glyburide: a one-year comparison trial Thomas Marbury, Won‐Chin Huang, Poul Strange, Diabetes Research and Clinical Practice MedicineClinical PharmacologyPharmacotherapyReagentRepaglinide Versus Glyburide	1999	187
Pharmacokinetics of Micafungin in Healthy Volunteers, Volunteers With Moderate Liver Disease, and Volunteers With Renal Dysfunction Mary F. Hébert, Helen Smith, Thomas Marbury, The Journal of Clinical Pharmacology PharmacotherapyPhysiologically-based Pharmacokinetic ModelingPharmacokineticsSecondary MetabolismRenal Function	2005	178
Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1 Richard E. Nettles, Min Gao, Marc Bifano, Hepatology	2010	177
Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir Larissa Wenning, William D. Hanley, Diana M. Brainard, Antimicrobial Agents and Chemotherapy ImmunologyPharmacotherapyAntimicrobial ChemotherapyAntiviral DrugDrug Resistance	2009	160

Page 1